Myfortic Novartis Pharma AG - Treatment for Prevention of Organ Rejection

Myfortic is an enteric-coated formulation of mycophenolic acid for use in combination with cyclosporine and corticosteroids to prevent organ rejection in kidney transplant patients.

Posted: February 2004

Myfortic (mycophenolic acid) FDA Approval History

View comments

Hide
(web1)